We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
-14.04%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$627M
AUM Growth
+$7.4M
(+1.2%)
Cap. Flow
+$125M
Cap. Flow
% of AUM
20.01%
Top 10 Holdings %
Top 10 Hldgs %
49.49%
Holding
67
New
8
Increased
17
Reduced
20
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPNE
SeaSpine Holdings Corporation Common Stock
SPNE
|
+$30.1M |
| 2 |
NVTR
Nuvectra Corporation Common Stock
NVTR
|
+$14.9M |
| 3 |
Nektar Therapeutics
NKTR
|
+$14.4M |
| 4 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
+$14.3M |
| 5 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
+$14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NeoGenomics
NEO
|
+$22.2M |
| 2 |
SHPG
Shire pic
SHPG
|
+$11.4M |
| 3 |
KTWO
K2M Group Holdings, Inc
KTWO
|
+$7.93M |
| 4 |
SGMO
SANGAMO THERAPEUTICS INC
SGMO
|
+$4.51M |
| 5 |
DVAX
Dynavax Technologies
DVAX
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 75.2% |
| 2 | Communication Services | 3.64% |
| 3 | Energy | 0.8% |
| 4 | Financials | 0.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $40.7M | 6.48% |
2,853,826
+472,680
| +20% | +$7.17M |
|
2
Omnicell
OMCL
$1.61B
| $40.5M | 6.45% |
660,655
-2,454
| -0.4% | -$166K |
|
|
SPNE
3
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $32.6M | 5.19% |
+1,785,071
| New | +$30.1M |
|
|
OXFD
4
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $32.1M | 5.12% |
2,514,552
+920,543
| +58% | +$14M |
|
5
Ionis Pharmaceuticals
IONS
$8.6B
| $31.9M | 5.09% |
590,010
+97,870
| +20% | +$4.99M |
|
6
AtriCure
ATRC
$1.92B
| $29.6M | 4.71% |
965,797
-3,396
| -0.4% | -$106K |
|
|
SHPG
7
DELISTED
Shire pic
SHPG
| $28.4M | 4.53% |
163,409
-65,236
| -29% | -$11.4M |
|
|
8
NeoGenomics
NEO
$1.96B
| $27.8M | 4.44% |
2,208,188
-1,492,739
| -40% | -$22.2M |
|
|
9
Nektar Therapeutics
NKTR
$2.39B
| $24M | 3.83% |
48,682
+23,845
| +96% | +$14.4M |
|
|
MODN
10
DELISTED
MODEL N, INC.
MODN
| $22.8M | 3.64% |
1,726,404
+391,805
| +29% | +$5.65M |
|
11
Harvard Bioscience
HBIO
$27.5M
| $22.3M | 3.55% |
700,959
+73,947
| +12% | +$2.91M |
|
12
Heron Therapeutics
HRTX
$93.9M
| $21.4M | 3.41% |
825,269
-7,732
| -0.9% | -$213K |
|
|
XENT
13
DELISTED
Intersect ENT, Inc
XENT
| $19.8M | 3.15% |
701,398
+184,277
| +36% | +$5.4M |
|
|
IMMU
14
DELISTED
Immunomedics Inc
IMMU
| $19.4M | 3.09% |
1,360,280
+208,658
| +18% | +$4.14M |
|
15
Veracyte
VCYT
$3.7B
| $19.2M | 3.06% |
1,523,405
+335,711
| +28% | +$3.97M |
|
|
NVTR
16
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $19M | 3.03% |
1,162,451
+779,543
| +204% | +$14.9M |
|
17
Codexis
CDXS
$151M
| $17.7M | 2.82% |
1,059,359
+221,811
| +26% | +$3.83M |
|
18
Xencor
XNCR
$1.5B
| $16.8M | 2.69% |
465,770
-1,883
| -0.4% | -$69.1K |
|
|
CSII
19
DELISTED
Cardiovascular Systems, Inc.
CSII
| $13.7M | 2.19% |
482,104
-2,350
| -0.5% | -$74.7K |
|
20
Halozyme
HALO
$9.79B
| $13.7M | 2.19% |
938,399
+52,876
| +6% | +$844K |
|
21
Ligand Pharmaceuticals
LGND
$5.76B
| $12.8M | 2.04% |
151,294
+34,243
| +29% | +$3.65M |
|
22
Tandem Diabetes Care
TNDM
$1.34B
| $10M | 1.6% |
263,883
| – | – |
|
|
KDNY
23
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $9.42M | 1.5% |
+713,791
| New | +$14.3M |
|
|
VAPO
24
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $6.08M | 0.97% |
+38,064
| New | +$5.49M |
|
25
OraSure Technologies
OSUR
$279M
| $5.98M | 0.95% |
+512,216
| New | +$6.81M |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q4 2018 Portfolio in Review
As of Q4 2018, First Light Asset Management held 67 positions worth $627M, up 1.2% from $620M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
First Light Asset Management deployed $125M of net new capital in Q4 2018, opening 8 new positions and adding to 17 existing holdings. Its largest new stake was SeaSpine Holdings Corporation Common Stock: 1,785,071 shares worth $32.6M.
By sector, the portfolio is most concentrated in Healthcare at 75% of assets, down from 84% a quarter earlier, followed by Communication Services and Energy.
On the sell side, the largest reduction was NeoGenomics, an estimated $22.2M trimmed.
- First Light Asset Management's largest Q4 2018 buy was SeaSpine Holdings Corporation Common Stock: 1,785,071 shares worth $32.6M.
- First Light Asset Management added most to Nuvectra Corporation Common Stock in Q4 2018, an estimated $14.9M increase.
- First Light Asset Management's biggest Q4 2018 reduction was NeoGenomics, cutting an estimated $22.2M.
- First Light Asset Management fully exited K2M Group Holdings, Inc in Q4 2018, selling an estimated $7.93M.
- First Light Asset Management's ten largest holdings make up 49% of its $627M portfolio in Q4 2018.
- First Light Asset Management opened 8 new positions and closed 7 in Q4 2018.
- First Light Asset Management's portfolio value rose 1.2% quarter-over-quarter to $627M.
Based on First Light Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.